Lilly Ventures Fund I LLC 13D and 13G filings for Aeglea BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-12 4:59 pm Sale |
2020-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
Lilly Ventures Fund I LLC | 102,742 5.400% |
-3,227 (-3.04%) |
Filing |